Newly on Gate2Biotech

Business meeting at the IFF Water, seas, oceans

28.8.2012   |   Newly on Gate2Biotech

Don't miss a business meeting within the IFF "Water, Seas and The Oceans" with Czech-Indonesian Chamber of Commerce and Tourism, South Bohemian Chamber of Commerce and South Bohemian Agency for Support to Innovative Enterprising.

Continue


An outstanding start of the preparations – PHARM Connect Congress 2013

23.8.2012   |   Newly on Gate2Biotech

TEG is delighted to announce the dates of the 3rd PHARM Connect Congress – the annual market leading business summit in the field of pharmaceutical and biotechnology manufacturing in Central Eastern Europe and the CIS market.

Continue


Complete Agenda Released for Integrating Sample Preparation 2012 Conference

9.8.2012   |   Newly on Gate2Biotech

BOSTON, MA – July 31, 2012 – Leading organizations from around the world will convene in Baltimore for the Knowledge Foundation’s 6th Integrating Sample Preparation 2012 conference which will take place at the Sheraton Baltimore City Center from October 18-19, 2012. This meeting is an internationally recognized meeting for experts in sample...

Continue


Proteros announces successful close of financing round

6.8.2012   |   Newly on Gate2Biotech

Proteros biostructures GmbH (‘Proteros’) announced today that it had successfully closed a financing round of five million Euros to fund the continued expansion and growth of the company.

Continue


qPCR Experience® Boot Camp, Piran, Slovenia, 11.-14. September 2012

16.7.2012   |   Newly on Gate2Biotech

qPCR Experience Boot camp will focus on real-time PCR gene expression and microorganism detection but will also cover qPCR's other applications such as single cell qPCR, digital PCR and will include extensive practical sessions, a troubleshooting* section and lectures by Dr. Stephen A. Bustin.

Continue


Osiris Receives Second Approval for Life-Saving Stem Cell Drug

20.6.2012   |   Newly on Gate2Biotech

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today it has received consent from New Zealand to market its first-in-class stem cell therapy Prochymal® (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children. With this decision New Zealand joins Canada, which last month became the...

Continue


Enabling the next generation of stem cell research

13.6.2012   |   Newly on Gate2Biotech

Yokohama, Japan - One of the key challenges for cell therapy has been that growing human stem cells has been considered difficult, time consuming and varying in terms of quality. Basically the tools to work with stem cells have not been good enough previously. However, a Swedish biotechnology company BioLamina AB has developed an innovation to...

Continue


The most important meeting for biotechnology industry in Central Europe was held in Brno

3.6.2012   |   Newly on Gate2Biotech

On the 23rd-24th of May the biggest and the most important meeting for biotechnology industry in Central Europe was held in Brno in Czech Republic. The event was meant to gather scientists, businessmen, journalists, students and all those who are simply interested in this matter. The representatives of the following countries participated in this...

Continue


Prague Nobel Get-Together

28.5.2012   |   Newly on Gate2Biotech

we would like to cordially invite you to participate at the Prague Nobel Get-Together which will be held in Prague on May 30-31, 2012.

Continue


Hays Life Sciences HR Survey 2012

18.5.2012   |   Newly on Gate2Biotech

Life Sciences Employers are becoming more militant in the battle for talents. It is not only about sourcing the right professionals from the market but most of all creating the work environment to attract and retain them.

Continue


Page: Previous   11 12 13 14 15 16 17 18 19 20 21 22 23   Next

 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist